期刊文献+

6-(4-酰基-1-哌嗪乙酰氨基)-3,4-二氢-2(1H)-喹啉酮类化合物的合成及正肌力活性初探 被引量:6

Synthesis and positive inotropic activities test of 6-(4-acyl-1-piperazinylacetamino)-3,4-dihydro-2(1H)-quinolinone derivatives
在线阅读 下载PDF
导出
摘要 目的 :寻找具有正性肌力活性的化合物。方法 :根据文献报道的二氢喹啉酮类正性肌力药物的结构特点 ,设计、合成了其类似物。以苯胺为起始原料经多步合成 ,对所得化合物用离体豚鼠心脏与主动脉观察了心肌收缩力、扩血管作用及心率。结果 :合成了 1 0个 6 ( 4 酰基 1 哌嗪乙酰氨基 ) 3 ,4 二氢 2 ( 1H) 喹啉酮类化合物 ( 4a~ 4j) ,均为未见文献报道的化合物。结论 :初步药理试验表明 ,化合物 ( 4h)显示了正性肌力及扩血管活性。 OBJECTIVE:To search compounds that have positive inotropic activities.METHODS:According to the reported structures of dihydroquinolinones that have positive inotropic activities,a series of analogues were designed and synthesized.These analogues were synthesized through several steps using aniline as a starting material.The biological tests with isolated guinea pig heat and aorta to measure cardiac contractility,angiectatic effects and heart rate.RESULTS:Ten new compounds of 3,4 dihydro 6 (4 acyl 1 piperazinyl acetamino) 2(1H) quinolinones(4a~4j) were synthesized.CONCLUSION:Preliminary pharmacological tests showed that 6 (4 benzoyl 1 piperazinylacetamino) 3,4 dihydro 2(1H) quinolinone(4h) had positive inotropic activity and angiectaic effect.
出处 《中国现代应用药学》 CSCD 2000年第3期206-208,共3页 Chinese Journal of Modern Applied Pharmacy
基金 吉林省科委资助课题!第 95 35 46号
关键词 正性肌力作用 强心药 二氢喹啉酮 合成 positive inotropic activity cardiotonics dihydroquinolinone synthesis
  • 相关文献

参考文献1

  • 1廖新成.1-苯甲酰基哌嗪的制备[J].中国医药工业杂志(信息版),1993,(1):21-21.

共引文献1

同被引文献49

  • 1吴纯鑫,戴立言,陈英奇,翁志学.6-氨基-3,4-二氢-2(1H)-喹啉酮的合成[J].中国医药工业杂志,2004,35(9):522-523. 被引量:3
  • 2辛晓林,杨立红,黄清荣,冯芹.藻蓝蛋白对离体蟾蜍心脏正性肌力作用研究[J].食品科学,2005,26(8):384-386. 被引量:4
  • 3朱忠宁,赵丁,任雷鸣.Urocortin对大鼠和兔离体心肌组织的选择性正性肌力效应[J].中国药理学与毒理学杂志,2005,19(6):428-435. 被引量:3
  • 4WANG Junmin,JUN Changsoo,CHAI Kyuyun,KWAK Kyungchell,QUAN Zheshan.Synthesis and anticonvulsant activity of 1-substituted benzyl- N-substituted-1, 2, 3-triazole-4-formamides[J].Progress in Natural Science:Materials International,2006,16(9):925-929. 被引量:2
  • 5Packer M, Carver JR, Rodeheffer RJ, et al.. Effect of milrinone on mortality in severe chronic heart failurel [J]. N Engl J Med ,1993,325(21) : 1468.
  • 6Zhang CB, Cui X, Hong L, etal.. Synthesis and positive inotropic activity o{ N-(4,5-dihydro-[ 1,2,4 ] triazolo[4,3-a] quinolin-7-yl)-2- ( piperazin- 1-yl) acetamide derivatives[J]. Bioorg Med Chem Lett, 2008,18 : 4606.
  • 7LEHTONEN L A, ANTILA S, PENTIKAINEN P J. Pharmacokinetics and pharmacodynamics of intravenous inotropic agents [ J ]. Clin Pharmacokinet, 2004, 43 : 187 - 203.
  • 8OOI H, COLUCCI W S. Pharmacological treatment of heart failure [ M ]. New York: McGraw-Hill professional ,2001:901 - 932.
  • 9PACKER M, CARVER J R, RODEHEFFER R Jet al. Effect of milrinone on mortality in severe chronic heart failure [ J ]. N Engl J Med, 1993,325 ( 21 ) : 1468.
  • 10ZHANG C B, CUI X, HONG L, et al. Synthesis and positive inotropic activity of N- (4,5-dihydro- [ 1,2,4 ] triazolo [ 4,3-a ] quinolin-7-yl) -2-( piperazin-l-yl ) acetamide derivatives [ J ]. Bioorg Med Chem Lett, 2008,18:4606 -4609.

引证文献6

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部